Lerdelimumab: 6B1, Anti-TGF-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology, Anti-Transforming-Growth-Factor-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology, CAT 152, Human Anti-TGF-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology, TGF-Beta-2 Monoclonal Antibody - Cambridge Antibody Technology

By  

Drugs in R&D, Vol. 3, Iss. 2, 2002-02 ,pp. : 106-108

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetic Evaluation of a Fully Human IgG2 Monoclonal Antibody in Patients with Inflammatory Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 4, 2010-09 ,pp. : 229-237

Bentham Science Publishers

Access to resources Recommend Favorite

Pineal melatonin in rats: suppression by the selective 2 -adrenoceptor agonist medetomidine

By Mustanoja S.M.   Hatonen T.   Johansson-Alila A.   Laakso M.-L.  

European Journal of Pharmacology, Vol. 326, Iss. 2, 1997-05 ,pp. : 229-236

Elsevier

Access to resources Recommend Favorite

Neuroprotection by the 2 -adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia

By Jolkkonen J.   Puurunen K.   Koistinaho J.   Kauppinen R.   Haapalinna A.   Nieminen L.   Sivenius J.  

European Journal of Pharmacology, Vol. 372, Iss. 1, 1999-05 ,pp. : 31-36

Elsevier

Access to resources Recommend Favorite

Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an 2 -adrenoceptor agonist

By Rabin B.C.   Tian-Zhi G.   Gregg K.   Maze M.  

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 51-59

Elsevier

Access to resources Recommend Favorite